Form 990 for tax year 2022

Revenue

Part VIII, the statement of revenue.

• 1f · All other contributions, gifts and grants

  $1,445,980

• 1g · Noncash contributions included above

  $1,414,261

• 2a · Program service revenue: SERVICE FEES FOR BLOOD COMPONENTS

  total $100,534,458 · related or exempt $100,534,458

• 2b · Program service revenue: LABORATORY SERVICES

  total $14,981,146 · related or exempt $14,981,146

• 2c · Program service revenue: CELLULAR THERAPIES FEES

  total $1,782,227 · related or exempt $1,782,227

• 3 · Investment income

  total $1,607,109 · excluded $1,607,109

• 7a · Gross sales of assets other than inventory

  securities $7,518,641 · other assets $83,670

• 7b · Less cost or other basis and sales expenses

  securities $7,668,307 · other assets $566

• 7c · Gain or loss

  securities -$149,666 · other assets $83,104

• 7d · Net gain or loss

  total -$66,562 · excluded -$66,562

• 11a · Other revenue: OTHER MISC. REVENUE

  total $1,133,828 · related or exempt $1,133,828

• 11b · Other revenue: PURCHASE REBATES

  total $295,109 · related or exempt $295,109

• 11c · Other revenue: PARKING REVENUE

  total $49,252 · unrelated business $49,252

• 11e · Other revenue, total

  $1,478,189

Functional expenses

Part IX, the statement of functional expenses.

• 1 · Grants to domestic organizations and governments

  total $52,270 · program services $52,270

• 2 · Grants to domestic individuals

  total $17,500 · program services $17,500

• 5 · Compensation of officers, directors and key employees

  total $2,727,375 · program services $1,145,995 · management and general $1,581,380

• 7 · Other salaries and wages

  total $42,499,949 · program services $39,625,908 · management and general $2,874,041

• 8 · Pension plan contributions

  total $2,500,553 · program services $2,181,438 · management and general $319,115

• 9 · Other employee benefits

  total $5,336,228 · program services $4,281,920 · management and general $1,054,308

• 10 · Payroll taxes

  total $3,159,739 · program services $2,895,216 · management and general $264,523

• 11b · Fees: legal

  total $94,899 · management and general $94,899

• 11c · Fees: accounting

  total $97,740 · management and general $97,740

• 11g · Fees: other

  total $43,918 · program services $29,879 · management and general $14,039

• 12 · Advertising and promotion

  total $4,306,979 · program services $4,201,833 · management and general $105,146

• 13 · Office expenses

  total $1,746,590 · program services $1,144,294 · management and general $602,296

• 14 · Information technology

  total $1,885,128 · program services $1,713,071 · management and general $172,057

• 16 · Occupancy

  total $2,863,218 · program services $2,474,483 · management and general $388,735

• 17 · Travel

  total $889,637 · program services $870,796 · management and general $18,841

• 19 · Conferences, conventions and meetings

  total $350,113 · program services $170,659 · management and general $179,454

• 20 · Interest

  total $52,681 · program services $49,054 · management and general $3,627

• 22 · Depreciation, depletion and amortization

  total $4,642,118 · program services $4,336,102 · management and general $306,016

• 23 · Insurance

  total $1,859,187 · management and general $1,859,187

• 24a · Other expenses: COLLECTION & LAB SUPPLY

  total $15,925,129 · program services $15,921,510 · management and general $3,619

• 24b · Other expenses: REAGENTS

  total $10,281,983 · program services $10,281,983

• 24c · Other expenses: ALL OTHER EXPENSES

  total $3,603,651 · program services $3,343,768 · management and general $259,883

• 24d · Other expenses: BLOOD COMPONENT IMPORTS

  total $2,613,277 · program services $2,613,277

Balance sheet

Part X, book values.

• 1 · Cash, non-interest-bearing

  beginning of year $22,249,497 · end of year $20,936,467

• 2 · Savings and temporary cash investments

  beginning of year $2,225,343 · end of year $244,615

• 4 · Accounts receivable

  beginning of year $13,211,657 · end of year $15,526,451

• 8 · Inventories for sale or use

  beginning of year $4,558,035 · end of year $5,735,643

• 9 · Prepaid expenses and deferred charges

  beginning of year $1,720,451 · end of year $1,874,676

• 10a · Land, buildings and equipment: cost or other basis

  $88,468,002

• 10b · Land, buildings and equipment: accumulated depreciation

  $56,883,356

• 10c · Land, buildings and equipment, net

  beginning of year $25,813,452 · end of year $31,584,646

• 11 · Investments: publicly traded securities

  beginning of year $72,250,482 · end of year $70,076,558

• 15 · Other assets

  beginning of year $1,711,372 · end of year $5,949,424

• 17 · Accounts payable and accrued expenses

  beginning of year $10,914,011 · end of year $13,893,460

• 19 · Deferred revenue

  beginning of year $328,119 · end of year $242,751

• 25 · Other liabilities

  beginning of year $0 · end of year $4,454,738

• 27 · Net assets without donor restrictions

  beginning of year $132,498,159 · end of year $133,332,531

• 28 · Net assets with donor restrictions

  beginning of year $0 · end of year $5,000

The filer's explanations (Part III)

PART I, LINE 1A

GROSS UP PAYMENTS ARE PROVIDED ON VEHICLE ALLOWANCE FOR THE CEO AND CMO.

PART I, LINE 3

ALL EXECUTIVE COMPENSATION IS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AND THE BOARD. COMPENSATION AMOUNTS ARE DETERMINED BASED ON INDEPENDENT SURVEYS AND COMPARABLE DATA TO ORGANIZATIONS OUR SIZE FOR NON-PROFITS, OTHER BLOOD CENTERS, AND GENERAL INDUSTRY. THIS PROCESS WAS LAST UNDERTAKEN IN DECEMBER 2022. ALL OTHER MANAGEMENT POSITIONS' (DIRECTORS) COMPENSATION ARE BASED ON COMPENSATION REVIEWS PERFORMED BY OUR HUMAN RESOURCES DEPARTMENT. THE HR DEPARTMENT OBTAINS INDEPENDENT SURVEYS FOR THESE POSITIONS AND OTHER COMPARABLE DATA TO DETERMINE THEIR RECOMMENDATION OF THE COMPENSATION. ALL SALARY RECOMMENDATIONS ARE REVIEWED AND APPROVED BY THE EXECUTIVES. THIS PROCESS WAS LAST UNDERTAKEN IN DECEMBER 2022.

PART I, LINE 4B

THE CEO AND CMO PARTICIPATE IN AN EXECUTIVE DEFERRED COMPENSATION (457F) NONVESTED PLAN. NONQUALIFIED CONTRIBUTIONS TO THE PLAN FOR THE CEO AND CMO FOR 2022 WERE AS FOLLOWS: BRIAN G. GANNON - NONQUALIFIED $21,460 SUSAN N. ROSSMAN, M.D, PH.D. - NONQUALIFIED $9,595

PART I, LINE 6

ALL EMPLOYEES PARTICIPATE IN A BONUS PLAN THAT IS DEPENDENT ON ACHIEVING COMPANY-WIDE GOALS. ONE GOAL IS TIED TO NET REVENUES OVER EXPENSES. PAYOUT PERCENTAGES FOR EXECUTIVES ARE SET BY THE COMPENSATION COMMITTEE AND ARE APPROVED BY THE COMPENSATION COMMITTEE AND BOARD PRIOR TO PAYMENT FOR ALL EXECUTIVES.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

• BLOOD CORPORATION OF AMERICA

  C · INACTIVE · TX · 100% owned · controlled entity

  Directly controlled by GCRBC